These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
634 related articles for article (PubMed ID: 30700946)
21. [Protective effect of Saccharomyces boulardii against intestinal mucosal barrier injury in rats with nonalcoholic fatty liver disease]. Liu YT; Li YQ; Wang YZ Zhonghua Gan Zang Bing Za Zhi; 2016 Dec; 24(12):921-926. PubMed ID: 28073414 [No Abstract] [Full Text] [Related]
22. Evaluation of Dietary Approaches for the Treatment of Non-Alcoholic Fatty Liver Disease: A Systematic Review. Saeed N; Nadeau B; Shannon C; Tincopa M Nutrients; 2019 Dec; 11(12):. PubMed ID: 31888132 [TBL] [Abstract][Full Text] [Related]
23. Liver Fat Scores Moderately Reflect Interventional Changes in Liver Fat Content by a Low-Fat Diet but Not by a Low-Carb Diet. Kabisch S; Bäther S; Dambeck U; Kemper M; Gerbracht C; Honsek C; Sachno A; Pfeiffer AFH Nutrients; 2018 Jan; 10(2):. PubMed ID: 29385034 [TBL] [Abstract][Full Text] [Related]
24. Effectiveness of a carbohydrate restricted diet to treat non-alcoholic fatty liver disease in adolescents with obesity: Trial design and methodology. Dowla S; Pendergrass M; Bolding M; Gower B; Fontaine K; Ashraf A; Soleymani T; Morrison S; Goss A Contemp Clin Trials; 2018 May; 68():95-101. PubMed ID: 29601997 [TBL] [Abstract][Full Text] [Related]
25. [TEN-HOUR INTERMITTENT FASTING PLUS MEDITERRANEAN DIET VERSUS MEDITERRANEAN DIET ALONE FOR TREATMENT OF NONALCOHOLIC FATTY LIVER DISEASE (NAFLD)]. Milgrom Y; Massarwa M; Hazou W; Shafrir A; Mishraki E; Sanduka S; Safadi R; Benson A Harefuah; 2024 Feb; 163(2):93-96. PubMed ID: 38431857 [TBL] [Abstract][Full Text] [Related]
27. New Insights into the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Gut-Derived Lipopolysaccharides and Oxidative Stress. Ferro D; Baratta F; Pastori D; Cocomello N; Colantoni A; Angelico F; Del Ben M Nutrients; 2020 Sep; 12(9):. PubMed ID: 32927776 [TBL] [Abstract][Full Text] [Related]
28. Effect of Indo-Mediterranean diet versus calorie-restricted diet in children with non-alcoholic fatty liver disease: A pilot randomized control trial. Deshmukh A; Sood V; Lal BB; Khanna R; Alam S; Sarin SK Pediatr Obes; 2024 Nov; 19(11):e13163. PubMed ID: 39223952 [TBL] [Abstract][Full Text] [Related]
29. Response of fibroblast growth factor 19 and bile acid synthesis after a body weight-adjusted oral fat tolerance test in overweight and obese NAFLD patients: a non-randomized controlled pilot trial. Friedrich D; Marschall HU; Lammert F BMC Gastroenterol; 2018 Jun; 18(1):76. PubMed ID: 29866129 [TBL] [Abstract][Full Text] [Related]
30. Barriers and Facilitators to Mediterranean Diet Adoption by Patients With Nonalcoholic Fatty Liver Disease in Northern Europe. Haigh L; Bremner S; Houghton D; Henderson E; Avery L; Hardy T; Hallsworth K; McPherson S; Anstee QM Clin Gastroenterol Hepatol; 2019 Jun; 17(7):1364-1371.e3. PubMed ID: 30391437 [TBL] [Abstract][Full Text] [Related]
31. The Effect of Probiotics (MCP Mohamad Nor MH; Ayob N; Mokhtar NM; Raja Ali RA; Tan GC; Wong Z; Shafiee NH; Wong YP; Mustangin M; Nawawi KNM Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579068 [TBL] [Abstract][Full Text] [Related]
32. Metabolites of arachidonic acid and linoleic acid in early stages of non-alcoholic fatty liver disease--A pilot study. Maciejewska D; Ossowski P; Drozd A; Ryterska K; Jamioł-Milc D; Banaszczak M; Kaczorowska M; Sabinicz A; Raszeja-Wyszomirska J; Stachowska E Prostaglandins Other Lipid Mediat; 2015 Sep; 121(Pt B):184-9. PubMed ID: 26408952 [TBL] [Abstract][Full Text] [Related]
33. The effects of Mediterranean diet on hepatic steatosis, oxidative stress, and inflammation in adolescents with non-alcoholic fatty liver disease: A randomized controlled trial. Yurtdaş G; Akbulut G; Baran M; Yılmaz C Pediatr Obes; 2022 Apr; 17(4):e12872. PubMed ID: 34881510 [TBL] [Abstract][Full Text] [Related]
34. A comprehensive approach to lifestyle intervention based on a calorie-restricted diet ameliorates liver fat in overweight/obese patients with NAFLD: a multicenter randomized controlled trial in China. Liu Z; Jin P; Liu Y; Zhang Z; Wu X; Weng M; Cao S; Wang Y; Zeng C; Yang R; Liu C; Sun P; Tian C; Li N; Zeng Q Nutr J; 2024 Jun; 23(1):64. PubMed ID: 38872173 [TBL] [Abstract][Full Text] [Related]
35. Dietary Composition Independent of Weight Loss in the Management of Non-Alcoholic Fatty Liver Disease. Eslamparast T; Tandon P; Raman M Nutrients; 2017 Jul; 9(8):. PubMed ID: 28933748 [TBL] [Abstract][Full Text] [Related]
36. Increased Colonic Permeability and Lifestyles as Contributing Factors to Obesity and Liver Steatosis. Di Palo DM; Garruti G; Di Ciaula A; Molina-Molina E; Shanmugam H; De Angelis M; Portincasa P Nutrients; 2020 Feb; 12(2):. PubMed ID: 32098159 [TBL] [Abstract][Full Text] [Related]
37. Effect of Dietary and Lifestyle Interventions on the Amelioration of NAFLD in Patients with Metabolic Syndrome: The FLIPAN Study. Montemayor S; Bouzas C; Mascaró CM; Casares M; Llompart I; Abete I; Angullo-Martinez E; Zulet MÁ; Martínez JA; Tur JA Nutrients; 2022 May; 14(11):. PubMed ID: 35684022 [TBL] [Abstract][Full Text] [Related]
38. Association between Mediterranean Diet and Fatty Liver in Women with Overweight and Obesity. Leone A; Bertoli S; Bedogni G; Vignati L; Pellizzari M; Battezzati A Nutrients; 2022 Sep; 14(18):. PubMed ID: 36145146 [TBL] [Abstract][Full Text] [Related]
39. Effects of low fat diet on inflammatory parameters in individuals with obesity/overweight and non-alcoholic fatty liver disease: A cross-sectional study. Erdem NB; Kahramanoğlu Aksoy E; Dikmen D; Uçar Baş K; Ağaçdiken A; İlhan Esgin M; Göktaş Z Medicine (Baltimore); 2024 Apr; 103(15):e37716. PubMed ID: 38608067 [TBL] [Abstract][Full Text] [Related]
40. Association between Non-Alcoholic Fatty Liver Disease and Mediterranean Lifestyle: A Systematic Review. Mascaró CM; Bouzas C; Tur JA Nutrients; 2021 Dec; 14(1):. PubMed ID: 35010923 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]